Most people are familiar with A, B, AB and O blood types, but there are hundreds of additional blood group “antigens” on red blood cells – substances that can trigger the body’s immune response – that differ from person to person. Each year, up to 16 deaths reported to the Federal Drug Administration are attributed to mismatches in red blood cell antigens that are not related to differences in A, B and O blood groups. Currently, no method is available that can determine all blood antigens. But as whole genome sequencing becomes routine for patients, it may be possible to modernize therapy by identifying both rare donors and at-risk recipients before blood transfusions.
In a new study, investigators from Brigham and Women’s Hospital and Harvard Medical School, as well as from the New York Blood Center have leveraged the MedSeq Project – the first randomized trial of whole genome sequencing in healthy adults – to develop and validate a computer program that can comprehensively and cost-effectively determine differences in individuals’ blood types with more than 99 percent accuracy. The team’s results are reported in The Lancet Haematology.
“Blood transfusion complications are common in patients needing chronic transfusion, but with current technology it is not cost effective to do blood typing for all antigens,” said first author William Lane, MD, PhD, director of Clinical Laboratory Informatics and assistant director of the Tissue Typing Laboratory in the BWH Department of Pathology. “But the algorithm we have developed can be applied to type everyone for all relevant blood groups at a low cost once sequencing is obtained.”
Blood transfusions are one of the most common procedures in medicine with more than 11 million units of blood transfused in the U.S. each year. Complications from blood transfusions can be life-threatening. When the body encounters foreign antigens on the donor cells, it can stimulate production of antibodies that can destroy the transfused donor cells. From birth, people have antibodies unique to their ABO blood type, but other antibodies against specific blood antigens can be stimulated during pregnancy from exposure to fetal cells or exposure to donor cells when receiving multiple blood transfusions.
“This approach has the potential to be one of the first routine clinical uses of genomics for medical care for patients needing blood transfusion,” said co-first author Connie M. Westhoff, PhD, at the New York Blood Center. “It could prevent serious or even fatal complications because once patients are sensitized they have a life-long risk of hemolytic transfusion reactions if blood transfusion is needed in an emergency.”
Today, most testing for blood donors and patients include only ABO and Rh matching, but more than 300 red blood cell antigens and 33 platelet antigens are known. To create a way to cost-effectively type many people for these antigens, Lane teamed up with scientists directing the MedSeq Project and experts in blood group genetics at the New York Blood Center to build a database and develop a computer software algorithm, known as bloodTyper, that could rapidly and accurately predict an individual’s blood group antigen profile from genomic sequences. Lane, Westhoff and colleagues validated the software by comparing it to traditional, and more labor-intensive, methods. bloodTyper was more than 99 percent accurate when typing from the MedSeq Project participants’ genomes. Lane notes that this work would not have been possible without access to samples from the MedSeq Project, and close collaboration with MedSeq’s principal investigator, Robert Green, MD, MPH, and co-investigator, Heidi Rehm, PhD.
“This report demonstrates a previously unanticipated use case and benefit that will accrue as whole genome sequencing become a routine part of medical care,” said Green, one of the senior authors on the study, director of the Genomes2People Research Program at BWH and professor of medicine at Harvard Medical School. “Genome sequencing can now identify potential transfusion recipients who need rare blood types and the individuals who can safely provide them.”
The Latest on: Whole genome sequencing
via Google News
The Latest on: Whole genome sequencing
- MediaPlanet and Dante Labs Team Up to Highlight the Role of Whole… on September 14, 2018 at 12:10 pm
NGS has been revolutionizing healthcare and enabling personalized medicine. “The coverage Whole Genome Sequencing provides makes for an extremely informative tool” says Andrea Riposati, Co-Founder of ... […]
- MediaPlanet and Dante Labs Team Up to Highlight the Role of Whole Genome Sequencing within Rare Diseases on September 14, 2018 at 12:01 pm
Today, Mediaplanet announces the launch of this September's edition of "Rare Diseases." This campaign will showcase the innovative work being done within rare diseases research, diagnostics, and will ... […]
- New study: Next generation sequencing (NGS) market estimated at USD 16.6 billion by 2025 | CAGR: 18.4% on September 14, 2018 at 6:03 am
Enquiry Report @ www.polarismarketresearch.com/indu…ire-before-buying By Technology, the global next generation sequencing market is further sub segmented into Whole Genome Sequencing, Targeted Re-Seq... […]
- Experts Advise Against Universal DNA Sequencing of Newborns on September 13, 2018 at 9:24 pm
The authors note that targeted or whole-exome or whole-genome sequencing can be used to assist in the diagnosis of symptomatic newborns, with parental permission and access to genetic counseling and f... […]
- Ribotyping Easily Fills in for Whole Genome Sequencing to Characterise Foods-borne Pathogens on September 13, 2018 at 2:06 am
Whole genome sequencing (WGS) has become the ultimate test to display the order of every base pair in an entire length of DNA… Whole genome sequencing (WGS) has become the ultimate test for determinin... […]
- Genome Medical Introduces the New "Understand Your Genome" Program to Increase Access to Genetics Education and Expertise on September 11, 2018 at 5:00 am
Individuals will be informed about a wide range of genomic services and testing options; from genetic health screening and targeted gene panel testing to exome sequencing and whole genome sequencing. ... […]
- Global Sequencing Market to Reach $8.9 Billion in 2022 as Applications Bloom on September 10, 2018 at 4:38 am
Thus far, NGS technologies have been most commonly used in research to perform whole genome sequencing, targeted sequencing, RNA sequencing, ChIP sequencing and methylation sequencing. These types ... […]
- Whole Genome Sequencing Identifies New Genetic Signature for Autism on August 14, 2018 at 3:41 am
Newswise — Autism has genetic roots, but most cases can’t be explained by current genetic tests. Now, patterns found in autistic children’s genomes – the complete set of genetic instructions inside ce... […]
- Dante Labs Offers $349 Whole Genome Sequencing on Amazon Prime Day on July 16, 2018 at 7:52 am
Dante Labs developed an offer for whole genome sequencing at $349 (299) for 36 hours only, on Amazon Prime Day July 16 and 17 2018. NEW YORK - July 16, 2018 - (Newswire.com) International biotech comp... […]
via Bing News